Valrubicin (N-trifluoroacetyladriamycin-14-valerate trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin and is administered by infusion directly into the bladder.It was originally launched as Valstar in the U.S.
This page contains content from the copyrighted Wikipedia article "Valrubicin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
